Find clinical trials for Asthma in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Cincinnati, OH, USA:
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Cincinnati, Ohio, United States and 80 other locations
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
Cincinnati, Ohio, United States and 6 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Cincinnati, Ohio, United States and 125 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Cincinnati, Ohio, United States and 117 other locations
Primary Objective:To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a pre...
Phase 3
Cincinnati, Ohio, United States and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Cincinnati, Ohio, United States and 97 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Cincinnati, Ohio, United States and 67 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
Cincinnati, Ohio, United States and 44 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Cincinnati, Ohio, United States and 141 other locations
ARS-1 is being developed for patients as a needleless alternative route of epinephrine administration for the management of refractory asthma...
Phase 2
Cincinnati, Ohio, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal